CVN424, a GPR6 inverse agonist, for Parkinson's disease and motor fluctuations: a double-blind, randomized, phase 2 trial
| Autor: | Brice, Nicola L., Carlton, Mark, Margolin, David H., Bexon, Martin, Matthews, Kim L., Dawson, Lee A., Ellenbogen, Aaron L., Olanow, C. Warren, Dubow, Jordan, Kieburtz, Karl |
|---|---|
| Zdroj: | In eClinicalMedicine November 2024 77 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|